Critical Psychiatry Textbook, Chapter 2: Are Psychiatric Disorders Mainly Genetic or Environmental? (Part One)
This chapter from Peter Gøtzsche’s Critical Psychiatry Textbook has been reproduced by Mad in America. It begins. “Textbook authors are preoccupied with telling the students that psychiatric disorders are hereditary. Obviously, this gives the specialty prestige. It makes it look more scientific to claim…
Read more
No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study
This article by Reinhard Maß, Kerstin Backhaus, Katharina Lohrer, Michael Szelies and Bodo K. Unkelbach has been published in Psychopharmacology. The abstract says: “Rationale Antidepressants (AD) are mostly considered indispensable for the treatment of major depression. The vast majority of…
Read more
A Neuroscientist Evaluates the Standard Biological Model of Depression
This research article by Peter Sterling (Professor of Neuroscience) has been published by Mad in America. It begins: “Abstract Neuroscientists widely hypothesize that ‘depression’ arises from a brain disorder caused by some defect in a specific neural pathway. If so, we might identify…
Read more
Not My Words, Not My Story by Julia Buxton
Causality in Mental Disturbance: A Review of the Neuroscience
“To be clear: there is no neuroscience to suggest that any mental function would be improved by ablating or stimulating a particular structure in the prefrontal cortex or its associated subcortical regions. To the contrary, what we know of the intrinsic organization…
Read more
Framing Depression as a Functional Signal Rather than a Disease Promotes Hope and Reduces Stigma, Study Finds
Rates of Prolonged Grief Disorder: Considering relationship to the person who died and cause of death
This research paper – from Kara Thieleman, Joanne Cacciatore, and Allen Frances – has been published in the Journal of Affective Disorders. The abstract says: Background Prolonged Grief Disorder (PGD) was recently included in DSM-5-TR. The rate of PGD is known to…
Read more
Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines
“Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals“ Shanti Das and Jon Ungoed-Thomas report for The Observer: “Drug companies are systematically funding grassroots patient groups that lobby the NHS medicines watchdog to approve…
Read more